Research programme: G protein coupled receptor modulator therapeutics - Salipro Biotech
Latest Information Update: 28 Jun 2024
Price :
$50 *
At a glance
- Originator Salipro Biotech
- Class Analgesics; Antineoplastics; Immunotherapies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; CNS disorders; Neurological disorders; Pain
Most Recent Events
- 28 Jun 2024 Discontinued for Immunological disorders in Sweden (unspecified route) (Salipro Biotech pipeline, June 2024)
- 28 Jun 2024 Discontinued for Pain in Sweden (unspecified route) (Salipro Biotech pipeline, June 2024)
- 28 Jun 2024 Discontinued for Cancer in Sweden (unspecified route) (Salipro Biotech pipeline, June 2024)